Cao Hongbin, Guo Genrui, Wu Wenjing, Cheng Zhenghai
Department of Neurosurgery, Hebei Children's Hospital, Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Anesthesiology, Hebei Children's Hospital, Hebei Medical University, Shijiazhuang, Hebei, China.
Chin Neurosurg J. 2024 Dec 26;10(1):34. doi: 10.1186/s41016-024-00386-z.
A nonadjustable state of the programmable shunt valve is a rare phenomenon. This case report aims to explore the cause of pressure adjustment dysfunction in a programmable shunt valve in a middle cranial fossa arachnoid cyst-peritoneal shunt patient and to underscore this dysfunction as an indicator of shunt valve obstruction.
A child with a ruptured giant arachnoid cyst in the left middle cranial fossa presented with acute intracranial hypertension following head trauma. The initial cysto-peritoneal shunt surgery rapidly alleviated symptoms, including headaches, vomiting, and left cranial nerve palsy, stabilizing the clinical condition. However, between 20 and 24 months after the initial shunt surgery, the patient developed intermittent shunt dysfunction, experiencing recurrent headaches and vomiting, during which the programmable valve's pressure setting had become fixed and was no longer adjustable. A second surgery was then performed to remove the existing shunt, excise the fibrotic cyst wall, fenestrate the basal cistern, and establish temporary subdural drainage. During this operation, extensive fibrosis of the cyst wall in the subdural space was discovered, forming a tough and hypertrophic fibrotic membrane that encased the cerebral hemispheres. This fibrotic material nearly filled the shunt valve chamber, causing valve obstruction and immobilizing the pressure control rod, resulting in pressure adjustment dysfunction. As the patient could not maintain stability without continuous drainage, a third surgery was ultimately necessary to place a subdural-peritoneal shunt. Five years of follow-up revealed no significant clinical symptoms, and the patient has maintained a normal life.
Shunt valve obstruction is an underestimated cause of shunt system failure, with no current definitive method for early diagnosis. Fibrotic deposition is a primary mechanism underlying shunt valve obstruction. Pressure adjustment dysfunction in a programmable shunt valve serves as a reliable indicator of shunt valve obstruction. Further research should prioritize the treatment and prevention of shunt valve obstructions to improve outcomes in neurosurgical practice.
可编程分流阀处于不可调节状态是一种罕见现象。本病例报告旨在探讨一名中颅窝蛛网膜囊肿 - 腹腔分流患者的可编程分流阀压力调节功能障碍的原因,并强调这种功能障碍是分流阀阻塞的一个指标。
一名左中颅窝巨大蛛网膜囊肿破裂的儿童在头部外伤后出现急性颅内高压。初次囊肿 - 腹腔分流手术迅速缓解了症状,包括头痛、呕吐和左侧颅神经麻痹,使临床状况稳定。然而,在初次分流手术后20至24个月期间,患者出现间歇性分流功能障碍,反复出现头痛和呕吐,在此期间可编程阀的压力设置变得固定且不再可调节。随后进行了第二次手术,移除现有的分流装置,切除纤维化的囊肿壁,打开基底池,并建立临时硬膜下引流。在这次手术中,发现硬膜下间隙的囊肿壁广泛纤维化,形成了一层坚韧且肥厚的纤维膜,包裹着大脑半球。这种纤维化物质几乎充满了分流阀腔,导致阀门阻塞并使压力控制杆固定不动,从而导致压力调节功能障碍。由于患者在没有持续引流的情况下无法维持稳定,最终需要进行第三次手术以放置硬膜下 - 腹腔分流。五年的随访显示没有明显的临床症状,患者维持了正常生活。
分流阀阻塞是分流系统故障的一个被低估的原因,目前尚无早期诊断的确切方法。纤维化沉积是分流阀阻塞的主要机制。可编程分流阀的压力调节功能障碍是分流阀阻塞的可靠指标。进一步的研究应优先考虑分流阀阻塞的治疗和预防,以改善神经外科实践中的治疗效果。